ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Post Starts Series With Horror Stories On Drug Testing; DeVita Says They Are “Slanted, Distorted”

October 23, 1981

NCI Trials Listed

June 25, 2010

Hiring Freeze Squeezes NIH, NCI

August 3, 1979

From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas

January 27, 2012

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

New Tenure Program Begins, NIH May Have 20-30 Positions Open

August 5, 1994